A citation-based method for searching scientific literature

Iris van Oostrom, Hanne Meijers-Heijboer, Litanja N Lodder, Hugo J Duivenvoorden, Arthur R van Gool, Caroline Seynaeve, Conny A van der Meer, Jan G M Klijn, Bert N van Geel, Curt W Burger, Juriy W Wladimiroff, Aad Tibben. J Clin Oncol 2003
Times Cited: 191







List of co-cited articles
764 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
26

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
25

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
20



Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort.
M Watson, C Foster, R Eeles, D Eccles, S Ashley, R Davidson, J Mackay, P J Morrison, P Hopwood, D G R Evans. Br J Cancer 2004
120
17

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
694
17

Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.
Joanna B Madalinska, Judith Hollenstein, Eveline Bleiker, Marc van Beurden, Heiddis B Valdimarsdottir, Leon F Massuger, Katja N Gaarenstroom, Marian J E Mourits, René H M Verheijen, Eleonora B L van Dorst,[...]. J Clin Oncol 2005
163
16

Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample.
Marc D Schwartz, Beth N Peshkin, Chanita Hughes, David Main, Claudine Isaacs, Caryn Lerman. J Clin Oncol 2002
175
16

The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal?
Tammy M Beran, Annette L Stanton, Lorna Kwan, Joyce Seldon, Julienne E Bower, Andrea Vodermaier, Patricia A Ganz. Ann Behav Med 2008
51
31

Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study.
Yvonne Brandberg, Kerstin Sandelin, Staffan Erikson, Göran Jurell, Annelie Liljegren, Annika Lindblom, Ann Lindén, Anna von Wachenfeldt, Marie Wickman, Brita Arver. J Clin Oncol 2008
140
16

One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).
Litanja N Lodder, Petra G Frets, R Willem Trijsburg, E Johanna Meijers-Heijboer, Jan G M Klijn, Caroline Seynaeve, Albertus N van Geel, Madeleine M A Tilanus, Carina C M Bartels, Leon C Verhoog,[...]. Breast Cancer Res Treat 2002
127
16

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
817
16


Long-term reactions to genetic testing for BRCA1 and BRCA2 mutations: does time heal women's concerns?
Chanita Hughes Halbert, Jill E Stopfer, Jasmine McDonald, Benita Weathers, Aliya Collier, Andrea B Troxel, Susan Domchek. J Clin Oncol 2011
49
28

A systematic review of perceived risks, psychological and behavioral impacts of genetic testing.
Jodi T Heshka, Crystal Palleschi, Heather Howley, Brenda Wilson, Philip S Wells. Genet Med 2008
216
13

Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy.
Kelly A Metcalfe, Mary Jane Esplen, Vivek Goel, Steven A Narod. Psychooncology 2004
78
16

Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice.
Kristi D Graves, Patti Vegella, Elizabeth A Poggi, Beth N Peshkin, Angie Tong, Claudine Isaacs, Clinton Finch, Scott Kelly, Kathryn L Taylor, George Luta,[...]. Cancer Epidemiol Biomarkers Prev 2012
52
25

The hospital anxiety and depression scale.
A S Zigmond, R P Snaith. Acta Psychiatr Scand 1983
12

The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation.
A Finch, K A Metcalfe, J K Chiang, L Elit, J McLaughlin, C Springate, R Demsky, J Murphy, B Rosen, S A Narod. Gynecol Oncol 2011
126
12

Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up.
C Foster, M Watson, R Eeles, D Eccles, S Ashley, R Davidson, J Mackay, P J Morrison, P Hopwood, D G R Evans. Br J Cancer 2007
54
20

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003
11

Psychological responses to BRCA1 mutation testing: preliminary findings.
R T Croyle, K R Smith, J R Botkin, B Baty, J Nash. Health Psychol 1997
242
11

Psychological impact of genetic testing in women from high-risk breast cancer families.
B Meiser, P Butow, M Friedlander, A Barratt, V Schnieden, M Watson, J Brown, K Tucker. Eur J Cancer 2002
92
11

Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy.
M H Frost, D J Schaid, T A Sellers, J M Slezak, P G Arnold, J E Woods, P M Petty, J L Johnson, D L Sitta, S K McDonnell,[...]. JAMA 2000
209
11

Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
L C Hartmann, D J Schaid, J E Woods, T P Crotty, J L Myers, P G Arnold, P M Petty, T A Sellers, J L Johnson, S K McDonnell,[...]. N Engl J Med 1999
911
11

Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.
L C Hartmann, T A Sellers, D J Schaid, T S Frank, C L Soderberg, D L Sitta, M H Frost, C S Grant, J H Donohue, J E Woods,[...]. J Natl Cancer Inst 2001
474
11

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.
Kelly A Metcalfe, Daphna Birenbaum-Carmeli, Jan Lubinski, Jacek Gronwald, Henry Lynch, Pal Moller, Parviz Ghadirian, William D Foulkes, Jan Klijn, Eitan Friedman,[...]. Int J Cancer 2008
238
11

Satisfaction with prophylactic mastectomy and breast reconstruction in genetically predisposed women.
Paula J C Bresser, Caroline Seynaeve, Arthur R Van Gool, Cecile T Brekelmans, Hanne Meijers-Heijboer, Albert N van Geel, Marian B Menke-Pluijmers, Hugo J Duivenvoorden, Jan G M Klijn, Aad Tibben. Plast Reconstr Surg 2006
82
13

Looking different, feeling different: women's reactions to risk-reducing breast and ovarian surgery.
Nina Hallowell, Brandi Baylock, Louise Heiniger, Phyllis N Butow, Deepa Patel, Bettina Meiser, Christobel Saunders, Melanie A Price. Fam Cancer 2012
42
26

Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
I van Oostrom, H Meijers-Heijboer, H J Duivenvoorden, A H J T Bröcker-Vriends, C J van Asperen, R H Sijmons, C Seynaeve, A R van Gool, J G M Klijn, A Tibben. Clin Genet 2007
54
18

The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy.
P J C Bresser, C Seynaeve, A R Van Gool, M F Niermeijer, H J Duivenvoorden, S van Dooren, A N van Geel, M B Menke-Pluijmers, J G M Klijn, A Tibben. Eur J Cancer 2007
43
23

Psychological consequences of predictive genetic testing: a systematic review.
M Broadstock, S Michie, T Marteau. Eur J Hum Genet 2000
234
9

Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy.
Mark Robson, Martee Hensley, Richard Barakat, Carol Brown, Dennis Chi, Elizabeth Poynor, Kenneth Offit. Gynecol Oncol 2003
96
9

Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up.
Brita Arver, Aina Haegermark, Ulla Platten, Annika Lindblom, Yvonne Brandberg. Fam Cancer 2004
44
20

Psychological distress and quality of life associated with genetic testing for breast cancer risk.
Ashley Wilder Smith, Angela Liegey Dougall, Donna M Posluszny, Tamara J Somers, Wendy S Rubinstein, Andrew Baum. Psychooncology 2008
50
18

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
H Meijers-Heijboer, B van Geel, W L van Putten, S C Henzen-Logmans, C Seynaeve, M B Menke-Pluymers, C C Bartels, L C Verhoog, A M van den Ouweland, M F Niermeijer,[...]. N Engl J Med 2001
628
9

The BRCA Self-Concept Scale: a new instrument to measure self-concept in BRCA1/2 mutation carriers.
Mary Jane Esplen, Noreen Stuckless, Jonathan Hunter, Alexander Liede, Kelly Metcalfe, Gordon Glendon, Steven Narod, Kate Butler, Jenna Scott, Ellen Irwin. Psychooncology 2009
35
25

Living with genetic test results for hereditary breast and ovarian cancer.
Rebekah Hamilton, Janet K Williams, Heather Skirton, Barbara J Bowers. J Nurs Scholarsh 2009
29
31



Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
8

Psychological impact of receiving a BRCA1/BRCA2 test result.
L Lodder, P G Frets, R W Trijsburg, E J Meijers-Heijboer, J G Klijn, H J Duivenvoorden, A Tibben, A Wagner, C A van der Meer, A M van den Ouweland,[...]. Am J Med Genet 2001
114
8

A literature review of the psychological impact of genetic testing on breast cancer patients.
Kathryn J Schlich-Bakker, Herman F J ten Kroode, Margreet G E M Ausems. Patient Educ Couns 2006
62
12

A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.
David Cella, Chanita Hughes, Amy Peterman, Chih-Hung Chang, Beth N Peshkin, Marc D Schwartz, Lari Wenzel, Amy Lemke, Alfred C Marcus, Caryn Lerman. Health Psychol 2002
162
8

Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.
Sandra van Dijk, Daniëlle R M Timmermans, Hanne Meijers-Heijboer, Aad Tibben, Christi J van Asperen, Wilma Otten. J Clin Oncol 2006
59
13

Clinical follow-up after bilateral risk reducing ('prophylactic') mastectomy: mental health and body image outcomes.
P Hopwood, A Lee, A Shenton, A Baildam, A Brain, F Lalloo, G Evans, A Howell. Psychooncology 2000
84
9

What I wish I'd known before surgery: BRCA carriers' perspectives after bilateral salipingo-oophorectomy.
Danielle Campfield Bonadies, Anne Moyer, Ellen T Matloff. Fam Cancer 2011
37
21

Body image and psychological distress after prophylactic mastectomy and breast reconstruction in genetically predisposed women: a prospective long-term follow-up study.
Mariska den Heijer, Caroline Seynaeve, Reinier Timman, Hugo J Duivenvoorden, Kathleen Vanheusden, Madeleine Tilanus-Linthorst, Marian B E Menke-Pluijmers, Aad Tibben. Eur J Cancer 2012
45
17

Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer.
Jessica P Gopie, Marc A M Mureau, Caroline Seynaeve, Moniek M Ter Kuile, Marian B E Menke-Pluymers, Reinier Timman, Aad Tibben. Fam Cancer 2013
59
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.